Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-12 Sale | 2024-08-14 4:57 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 29,881 | $56.53 | $1,689,294 | 69,874 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 4:15 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 20,000 | $50.31 | $1,006,300 | 99,755 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 7:07 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 30,000 | $56.88 | $1,706,550 | 105,189 (Direct) | View |
| 2021-11-30 Purchase | 2021-12-01 9:41 pm | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 50,000 | $4.5101 | $225,505 | 150,000 (Indirect Direct) | View |
| 2021-02-17 Purchase | 2021-02-19 6:13 pm | Talis Biomedical Corp | TLIS | Posard Matthew L. Director | 62,500 | $16 | $1,000,000 | 62,500 (Direct) | View |
| 2021-01-11 Purchase | 2021-01-13 4:21 pm | DermTech Inc. | DMTK | Posard Matthew L. Director | 33,898 | $29.5 | $999,991 | 86,863 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-14 Option Award | 2024-06-17 5:03 pm | N/A 2034-06-14 | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:11 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 15,305 | $0 | 128,559 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 7:52 pm | N/A 2033-06-15 | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-12 5:28 pm | N/A 2033-06-09 | Talis Biomedical Corp | TLIS | Posard Matthew L. Director | 95,000 | $0 | 95,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:20 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 35,714 | $0 | 158,215 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 6:27 pm | 2024-05-05 2033-05-05 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 19,436 | $0 | 124,625 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-16 8:04 pm | N/A 2032-06-15 | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 86,467 | $0 | 86,467 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-13 5:41 pm | N/A 2032-06-09 | Talis Biomedical Corp | TLIS | Posard Matthew L. Director | 95,000 | $0 | 95,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:11 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 26,480 | $0 | 122,501 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-06 8:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 6,206 | $0 | 135,189 (Direct) | View |
Ownership | 2021-06-09 9:38 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Posard Matthew L. Director | 0 | $0 | 368,476 (Indirect) | View |
| 2021-05-26 Option Award | 2021-05-28 8:19 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 9,158 | $0 | 96,021 (Direct) | View |
| 2021-05-05 Option Award | 2021-05-06 8:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 5,230 | $0 | 128,983 (Direct) | View |
Ownership | 2021-02-11 7:13 pm | N/A 2030-02-11 | Talis Biomedical Corp | TLIS | Posard Matthew L. Director | 0 | $0 | 143,779 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-19 4:19 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 8,000 | $0 | 52,965 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-01 7:15 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 8,829 | $0 | 123,753 (Direct) | View |
| 2020-04-29 Exercise | 2020-05-01 4:24 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 9,702 | $6.94 | 44,965 (Direct) | View |
| 2020-04-29 Exercise | 2020-05-01 4:24 pm | N/A 2026-09-21 | DermTech Inc. | DMTK | Posard Matthew L. Director | 9,702 | $0 | 44,965 (Direct) | View |
| 2020-01-30 Option Award | 2020-02-03 4:15 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 6,000 | $0 | 35,263 (Direct) | View |
| 2019-12-31 Exercise | 2020-01-03 4:10 pm | N/A N/A | DermTech Inc. | DMTK | Posard Matthew L. Director | 15,994 | $0 | 29,263 (Direct) | View |